Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

Go back to Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
(NASDAQ: CMPS) Delayed: 11.69 -0.24 (2.01%)
Previous Close $11.93    52 Week High
Open $11.80    52 Week Low
Day High $11.95    P/E N/A 
Day Low $11.61    EPS
Volume 1,008,313